Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4878830
Max Phase: Preclinical
Molecular Formula: C43H41ClF3N5O7
Molecular Weight: 832.28
Molecule Type: Unknown
Associated Items:
ID: ALA4878830
Max Phase: Preclinical
Molecular Formula: C43H41ClF3N5O7
Molecular Weight: 832.28
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCOC(=O)c1[nH]c2cc(Cl)ccc2c1C(C(=O)NC(C)(C)C)N(Cc1cc(F)c(F)c(F)c1)C(=O)CCCC#Cc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O
Standard InChI: InChI=1S/C43H41ClF3N5O7/c1-5-59-42(58)37-35(27-15-14-25(44)20-31(27)48-37)38(40(56)50-43(2,3)4)52(21-23-18-29(45)36(47)30(46)19-23)34(54)13-8-6-7-10-24-11-9-12-26-28(24)22-51(41(26)57)32-16-17-33(53)49-39(32)55/h9,11-12,14-15,18-20,32,38,48H,5-6,8,13,16-17,21-22H2,1-4H3,(H,50,56)(H,49,53,55)
Standard InChI Key: WWXPWUMFQYKOPY-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 832.28 | Molecular Weight (Monoisotopic): 831.2647 | AlogP: 6.38 | #Rotatable Bonds: 11 |
Polar Surface Area: 157.98 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 10.31 | CX Basic pKa: | CX LogP: 5.78 | CX LogD: 5.78 |
Aromatic Rings: 4 | Heavy Atoms: 59 | QED Weighted: 0.05 | Np Likeness Score: -0.87 |
1. Wang B, Liu J, Tandon I, Wu S, Teng P, Liao J, Tang W.. (2021) Development of MDM2 degraders based on ligands derived from Ugi reactions: Lessons and discoveries., 219 [PMID:33862513] [10.1016/j.ejmech.2021.113425] |
Source(1):